Recombinant basic fibroblast growth factor (Beijing ShuangLu Pharmaceutical)

重组人碱性成纤维细胞生长因子（双鹭药业）

Report date: 2024/11/20 09:57:24

Base Information

Drug NameRecombinant basic fibroblast growth factor (Beijing ShuangLu Pharmaceutical)
Drug Alias NamerhbFGF (Beijing ShuangLu Pharmaceutical)rh-bFGF (Beijing ShuangLu Pharmaceutical)扶济复
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionAngiogenesis inducersFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsBurns
Global Approved IndicationsBurns
Approved Indications in ChinaBurns
Original Approved Country/TerritoryMainland China
Original Approved Date2000/02/03
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Sl Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBurns
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A